Skip to content
Abierto
Menu

Special notice

INTENT TO SOLE SOURCE Wolters Kluwer VitalLaw Platform Subscription FDA – 75F40126Q00066

FDA75F40126Q00066

Food and Drug Administration, FDA Office of Acquisitions and Grants Services. Periodical Publishers.

View on SAM.govMarkdown

Awarded

CCH Incorporated

$61,033.05 obligated so far on USAspending

Description

As published on SAM.gov.

The FDA / Office of the Commissioner (OC) / Office of the Chief Counsel (OCC) requires the renewal of an existing subscription to the Wolters Kluwer VitalLaw Platform. This will be a one-year Base with four-year Options period of performance for the subscriptions of Administrative Law Treatise, Food, Drug & Cosmetic Law Library, Generic & Innovator Drugs, and Medical Devices Library.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
CCH Incorporated
UEI
RLPXK3FU7DF6
CAGE
9D625
Vendor location
Riverwoods, IL
Contract
75F40126P00033, purchase order
Obligated
$61,033.05, potential $337,246
Actions
1 between April 27, 2026 and April 27, 2026
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Acquire Wolters Kluwer Vitallaw Legal Research Platform Subscription.
Match
solicitation number FDA75F40126Q00066 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. February 13, 2026

    Special notice

    Due February 24, 2026 at 1:00 PM EST. SAM.gov, notice 94abbd7d5ad64d9ea9f37ddcd6e18b11

Points of contact